P

Assignee

WATSON LAB INC

US29 patents

Top patents by PatentIndex Score

US5047244ASep 10, 1991

Mucoadhesive carrier for delivery of therapeutical agent

WATSON LAB INC252 citations96
US4900552AFeb 13, 1990

Mucoadhesive buccal dosage forms

WATSON LAB INC315 citations96
US7921999B1Apr 12, 2011

Peelable pouch for transdermal patch and method for packaging

WATSON LAB INC58 citations95
US6251866B1Jun 26, 2001

Conjugates targeted to the interleukin-2 receptor

WATSON LAB INC44 citations94
US5637313AJun 10, 1997

Chewable dosage forms

WATSON LAB INC156 citations93
US7087241B2Aug 8, 2006

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

WATSON LAB INC25 citations92
US6974591B2Dec 13, 2005

Method for producing a controlled-release preparation

WATSON LAB INC59 citations89
US7303763B2Dec 4, 2007

Compositions for conjugated estrogens and associated methods

WATSON LAB INC52 citations87
US7988995B1Aug 2, 2011

Pharmaceutical compositions for lipophilic drugs

WATSON LAB INC9 citations83
US7029694B2Apr 18, 2006

Compositions and methods for transdermal oxybutynin therapy

WATSON LAB INC15 citations83
US8911773B2Dec 16, 2014

Peelable pouch for transdermal patch and method for packaging

WATSON LAB INC4 citations81
US7938265B2May 10, 2011

Medicament dispenser and method

WATSON LAB INC7 citations81
US7081249B2Jul 25, 2006

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

WATSON LAB INC9 citations73
US7081251B2Jul 25, 2006

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

WATSON LAB INC8 citations73
US7081252B2Jul 25, 2006

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

WATSON LAB INC8 citations73
US7081250B2Jul 25, 2006

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

WATSON LAB INC8 citations73
US7799340B2Sep 21, 2010

Pharmaceutical compositions for lipophilic drugs

WATSON LAB INC7 citations72
US7946461B2May 24, 2011

Ampoule opener and associated methods

WATSON LAB INC9 citations69
US9611068B2Apr 4, 2017

Frangible shipping carton and associated methods

WATSON LAB INC1 citations60
US8038008B2Oct 18, 2011

Medicament dispenser and associated methods

WATSON LAB INC3 citations60
US7838029B1Nov 23, 2010

Mirtazapine solid dosage forms

WATSON LAB INC6 citations60
US7802682B2Sep 28, 2010

Systems for increasing compliance with a medicament treatment regime

WATSON LAB INC2 citations60
US7985419B1Jul 26, 2011

Divisible tablet and associated methods

WATSON LAB INC5 citations57
US11820776B2Nov 21, 2023

Process for the preparation of Remimazolam and solid state forms of Remimazolam salts

WATSON LAB INC0 citations52
US11034697B2Jun 15, 2021

Process for the preparation of Remimazolam and solid state forms of Remimazolam salts

WATSON LAB INC0 citations52
US10993943B2May 4, 2021

Crystalline forms of selinexor and process for their preparation

WATSON LAB INC0 citations51
US9422079B2Aug 23, 2016

Frangible shipping carton and associated methods

WATSON LAB INC0 citations49
US9259388B2Feb 16, 2016

Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions

WATSON LAB INC0 citations45
US11149017B2Oct 19, 2021

Solid state forms of apalutamide

WATSON LAB INC0 citations38